RYLDX
Price
$203.73
Change
-$0.21 (-0.10%)
Updated
Dec 26 closing price
Net Assets
41.48M
RYVYX
Price
$686.35
Change
-$0.75 (-0.11%)
Updated
Dec 26 closing price
Net Assets
1.55B
Interact to see
Advertisement

RYLDX vs RYVYX

Header iconRYLDX vs RYVYX Comparison
Open Charts RYLDX vs RYVYXBanner chart's image
Rydex Dow 2x Strategy A
Price$203.73
Change-$0.21 (-0.10%)
VolumeN/A
Net Assets41.48M
Rydex NASDAQ-100® 2x Strategy H
Price$686.35
Change-$0.75 (-0.11%)
VolumeN/A
Net Assets1.55B
RYLDX vs RYVYX Comparison Chart in %
View a ticker or compare two or three
VS
RYLDX vs. RYVYX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLDX is a Hold and RYVYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.55B vs. RYLDX (41.5M). RYLDX pays higher dividends than RYVYX: RYLDX (0.53) vs RYVYX (0.00). RYLDX was incepted earlier than RYVYX: RYLDX (21 years) vs RYVYX (26 years). RYLDX (1.87) and RYVYX (1.87) have similar cost to investors . RYLDX is a more actively managed with annual turnover of: 1015.00 vs. RYVYX (383.00). RYLDX (2500) and RYVYX (2500) have matching initial minimum investment requirements. RYLDX (16.61) and RYVYX (16.03) have marching annual gain over last year. RYVYX return over 5 years is better than : 112.84 vs. RYLDX (90.59).
RYLDXRYVYXRYLDX / RYVYX
Total Expense Ratio1.771.74102%
Annual Report Gross Expense Ratio1.871.87100%
Fund Existence21 years26 years-
Gain YTD21.10224.70585%
Front Load5%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets41.5M1.55B3%
Annual Yield % from dividends0.530.00-
Returns for 1 year16.6116.03104%
Returns for 3 years74.44270.0428%
Returns for 5 years90.59112.8480%
Returns for 10 years337.77747.5845%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPHRF11.130.15
+1.37%
Cipher Pharmaceuticals, Inc.
CHEOF175.01N/A
N/A
CochLear Ltd.
NDCVF12.25N/A
N/A
NORDIC SEMICONDUCTOR ASA
NBCDF18.48N/A
N/A
National Bank of Canada
EHSI1.26-0.05
-3.82%
Elite Health Systems, Inc.